UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

December 10, 2004

Date of Report (Date of earliest event reported)

 

ABBOTT LABORATORIES

(Exact name of registrant as specified in its charter)

 

Illinois

 

1-2189

 

36-0698440

(State or other Jurisdiction of
Incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

100 Abbott Park Road
Abbott Park, Illinois 60064-6400

(Address of principal executive offices)(Zip Code)

 

Registrant’s telephone number, including area code:  (847) 937-6100

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o                                    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o                                    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o                                    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o                                    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


 

 



 

Item 1.01  —  Entry into a Material Definitive Agreement.

 

On December 10, 2004, Abbott Laboratories’ Board of Directors amended the Abbott Laboratories 1996 Incentive Stock Program to allow for the award of restricted stock units in lieu of restricted stock to non-employee directors.

 

Item 9.01  —  Financial Statements and Exhibits.

 

(c)                     Exhibits

 

Exhibit No.

 

Exhibit

 

 

 

10.1

 

The Abbott Laboratories 1996 Incentive Stock Program, as amended and restated through the 3rd Amendment December 10, 2004

 

 

 

10.2

 

Form of Non-Employee Director Restricted Stock Unit Agreement under Abbott Laboratories 1996 Incentive Stock Program

 

2



 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ABBOTT LABORATORIES

 

 

 

 

 

/s/ Thomas C. Freyman

 

 

By:

Thomas C. Freyman

 

 

Executive Vice President, Finance
and Chief Financial Officer

 

 

 

 

Date: December 15, 2004

 

 

3



 

Exhibit Index

 

Exhibit No.

 

Exhibit

 

 

 

  10.1

 

The Abbott Laboratories 1996 Incentive Stock Program, as amended and restated through the 3rd Amendment December 10, 2004

 

 

 

  10.2

 

Form of Non-Employee Director Restricted Stock Unit Agreement under Abbott Laboratories 1996 Incentive Stock Program

 

4